NCT00770770

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

A Randomized, Double-masked, Pilot Study of the Safety and Efficacy of 0.5 µg/Day and 0.2 µg/Day Iluvien™ (Fluocinolone Acetonide Intravitreal Insert) 0.19 mg in Subjects With Macular Edema Secondary to Retinal Vein Occlusion

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Alimera Sciences · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will assess the safety and efficacy of FA Intravitreal Inserts in subjects with macular edema secondary to RVO.

Conditions

• Macular Edema
• Retinal Vein Occlusion

Interventions

Type	Name	Description
DRUG	Fluocinolone Acetonide	0.2 µg/day
DRUG	Fluocinolone Acetonide	0.5 µg/day

Timeline

• Start date: 2009-05-01
• Primary completion: 2013-10-01
• First posted: 2008-10-10
• Last updated: 2015-05-28
• Results posted: 2015-05-28

Locations

3 sites across 1 country: United States